NCT02756130 2025-05-13Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)Jonsson Comprehensive Cancer CenterPhase 1/2 Withdrawn